Publication | Open Access
German Multicenter Study Investigating<sup>177</sup>Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
812
Citations
22
References
2016
Year
The present retrospective multicenter study of <sup>177</sup>Lu-PSMA-617 RLT demonstrates favorable safety and high efficacy exceeding those of other third-line systemic therapies in mCRPC patients. Future phase II/III studies are warranted to elucidate the survival benefit of this new therapy in patients with mCRPC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1